A drug for unresectable hepatocellular carcinoma: tremelimumab

doi:10.3969/j.issn.1672-3384.2023.09.006

PDF(414 KB)

Clinical Medication Journal ›› 2023, Vol. 21 ›› Issue (9) : 25-29. DOI: 10.3969/j.issn.1672-3384.2023.09.006

Comment of New Drug

A drug for unresectable hepatocellular carcinoma: tremelimumab

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2023, 21(9): 25-29 https://doi.org/10.3969/j.issn.1672-3384.2023.09.006

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(414 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2023-06-08	2023-09-23
Issue Date
2023-09-23

Please choose a citation manager

Content to export